19 transactions on file, per SEC Form 4 filings.
See JNJ superinvestor activity →Pinto Daniel E
director · 2026-09-08
Award
113.098 sh
Woods Eugene A.
director · 2026-09-08
Award
135.717 sh
HEWSON MARILLYN A
director · 2026-09-08
Award
180.956 sh
Schmid Timothy
EVP, WW Chair, MedTech · 2026-09-02
Option exercise
$1.5M
Schmid Timothy
EVP, WW Chair, MedTech · 2026-09-02
Sold
$6.2M
Schmid Timothy
EVP, WW Chair, MedTech · 2026-09-02
Option exercise
$3.4M
Taubert Jennifer L
EVP, WWC. Innovative Medicine · 2026-08-17
Option exercise
$1.7M
Taubert Jennifer L
EVP, WWC. Innovative Medicine · 2026-08-17
Sold
$4.0M
Duato Joaquin
CEO and Chairman of the Board · 2026-08-13
Option exercise
$14.3M
Duato Joaquin
CEO and Chairman of the Board · 2026-08-13
Sold
$5.5M
Duato Joaquin
CEO and Chairman of the Board · 2026-08-13
Sold
$26.7M
Forminard Elizabeth
EVP, Chief Legal Officer · 2026-08-06
Option exercise
$1.2M
Forminard Elizabeth
EVP, Chief Legal Officer · 2026-08-06
Sold
$2.4M
Forminard Elizabeth
EVP, Chief Legal Officer · 2026-08-06
Sold
$1.7M
Duato Joaquin
CEO and Chairman of the Board · 2026-08-05
Sold
$10.8M
Duato Joaquin
CEO and Chairman of the Board · 2026-08-05
Sold
$1.7M
Broadhurst Vanessa
EVP, Global Corp Affairs · 2026-07-20
Option exercise
$1.6M
Broadhurst Vanessa
EVP, Global Corp Affairs · 2026-07-20
Option exercise
$1.4M
Broadhurst Vanessa
EVP, Global Corp Affairs · 2026-07-20
Sold
$5.8M
Each row links to the underlying SEC filing. Sells are shown for transparency, not as a signal — see the insider trading article for why.
Following an insider into a stock isn't a strategy on its own. Run your own margin-of-safety analysis, free.
Analyze JNJ